Pharmaceutical clinical research organizations are shifting phase II and III trials toward decentralized models. By deploying medical-grade remote monitoring hardware, sponsors can capture continuous physiological metrics in real-world settings.
Data Integrity Protocols
The integration of high-frequency sensor data requires robust cloud data pipelines equipped with automated artifact filtering. Regulatory agencies require audited data chains from device sensor to primary analytical endpoint.
Cost Efficiency
Early operational data indicates a 25% reduction in patient dropout rates, alongside significant reductions in site infrastructure expenditure.